NCT01013272View on ClinicalTrials.gov

Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Hepatitis B, Chronic
Interventions
DRUG

Entecavir

Entecavir 0.5mg orally daily

DRUG

Lamivudine

Lamivudine 100mg orally, daily

Trial Locations (1)

Unknown

The University of Hong Kong, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT01013272 - Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load | Biotech Hunter | Biotech Hunter